Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

medcomms

- PMLiVE

The real-world challenge pharma can’t ignore: Sustained engagement

Breakthrough therapies do not fail because the science stops working. They fail when healthcare is not designed for the physical, emotional and mental realities shaping how people engage with treatment...

Mednet

- PMLiVE

Where Making Health Whole began

Mental health providers revealed years ago what healthcare is only now beginning to recognise: information alone does not sustain engagement. This article explores how Mednet’s heritage in mental health has...

Mednet

Two_Women_Running_Making_Health_Whole

The silent drop-off: How disengagement shows up in everyday behaviour

In healthcare, disengagement rarely announces itself. It doesn’t always appear as refusal or a clear decision to stop treatment. More often, it shows up quietly, in what is delayed, avoided...

Mednet

- PMLiVE

Examining the health of the pharma: patient group relationship

Explore the positive aspects and areas for improvement in the relationship between patient advocacy groups and pharma companies when participating in research, educational initiatives and awareness campaigns.

Say Communications

- PMLiVE

Five things to know when engaging Gen Z patients

Learn more about Gen Z: who they are, where they can be reached and how they like to be engaged and find Say’s five tips to consider when engaging with...

Say Communications

- PMLiVE

BOLDADVOCACY Division of BOLDSCIENCE Strengthens Leadership Team with Tori Fahrney

BOLDSCIENCE, One of the Fastest-Growing Firms in the Health Care Sector, and the Minds + Assembly Platform Reinforce Importance of Supporting Patients and Caregivers

BOLDSCIENCE

- PMLiVE

What are “orphan drugs” and how do we navigate the challenges of writing about them?

The first in our 'Ask Alex' series, where Principal Medical Writer, Dr Alexandra Loveday answers some frequently asked questions about Medcomms. This week, she takes a look at 'orphan drugs',...

Mednet

- PMLiVE

Imagine More for the reporting of consensus programme outputs

The Bedrock team reflects on the latest published guidance in the development of consensus programmes

Resonant Group

- PMLiVE

BOLDSCIENCE launches BOLDAPPROVALS division

BOLDAPPROVALS, a new division of the medical communications agency BOLDSCIENCE, will help pharmaceutical and biotech clients gain regulatory approval with comprehensive services that include preparation for US Food and Drug...

BOLDSCIENCE

- PMLiVE

HCP ENGAGEMENT STUDY: Pharma shifts top priority to HCP insights and impact metrics

EPG Health publishes new multi-stakeholder research report on The Future of HCP Engagement Impact

EPG Health

- PMLiVE

The Power of Strong Partnerships

The Bedrock team reflects on what is critical to building strong partnerships.

Resonant Group

- PMLiVE

The MM+M Agency 100 report: Oxford PharmaGenesis is recognized as an industry leader for the third year running

We have scored a hat-trick, with media brand Medical Marketing and Media (MM+M) listing Oxford PharmaGenesis in its Agency 100 report for a third consecutive year.

Oxford PharmaGenesis

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links